DrugPatentWatch Database Preview
IMURAN Drug Profile
see a sample report or, see our see our flat-rate plans
When do Imuran patents expire, and when can generic versions of Imuran launch?
The generic ingredient in IMURAN is azathioprine. There are fifteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the azathioprine profile page.
Summary for IMURAN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 91 |
| Clinical Trials: | 18 |
| Patent Applications: | 4,585 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | IMURAN at DailyMed |
Pharmacology for IMURAN
| Ingredient-type | Nucleoside Analog Purines |
| Drug Class | Purine Antimetabolite |
| Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for IMURAN
Synonyms for IMURAN
| [Methyl(nitroimidazolyl)mercaptopurine] |
| 055A974 |
| 1767-EP0930075A1 |
| 1767-EP2272822A1 |
| 1767-EP2272825A2 |
| 1767-EP2272827A1 |
| 1767-EP2272832A1 |
| 1767-EP2275420A1 |
| 1767-EP2277865A1 |
| 1767-EP2277876A1 |
| 1767-EP2281815A1 |
| 1767-EP2292227A2 |
| 1767-EP2292614A1 |
| 1767-EP2295409A1 |
| 1767-EP2295412A1 |
| 1767-EP2295413A1 |
| 1767-EP2295426A1 |
| 1767-EP2295427A1 |
| 1767-EP2298743A1 |
| 1767-EP2301933A1 |
| 1767-EP2311827A1 |
| 1767-EP2311837A1 |
| 1767-EP2314590A1 |
| 1767-EP2316834A1 |
| 1767-EP2371811A2 |
| 1H-Purine, 6-((1-methyl-4-nitro-1H-imidazol-5-yl)thio)- |
| 1H-Purine, 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- |
| 446-86-6 |
| 446A866 |
| 55774-33-9 (hydrochloride salt) |
| 6-?[(1-?METHYL-?4-?NITRO-?1H-?IMIDAZOL-?5-?YL)THIO]-?9H-?PURINE |
| 6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine |
| 6-((1-methyl-4-nitro-1H-imidazol-5-yl)thio)-7H-purine |
| 6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-9H-purine |
| 6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine |
| 6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine |
| 6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine |
| 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin |
| 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech] |
| 6-(1-Methyl-4-nitroimidazol-5-ylthio)purine |
| 6-(1-Methyl-4-nitromidazol-5-ylthio)purine |
| 6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine |
| 6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine |
| 6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine |
| 6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine |
| 6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine |
| 6-(3-methyl-5-nitro-imidazol-4-yl)sulfanyl-7H-purine |
| 6-(3-methyl-5-nitro-imidazol-4-yl)sulfanyl-9H-purine |
| 6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine |
| 6-(Methyl-p-nitro-5-imidazolyl)-thiopurine |
| 6-(Methyl-p-nitro-5-imidazolyl)thiopurine |
| 6-[(1-Methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-1H-purine # |
| 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine |
| 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-9H-purine |
| 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine |
| 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine |
| 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine |
| 6-[(1-Methyl-4-nitroimidazol-5-yl)- thio] purine |
| 6-[(1-Methyl-4-nitroimidazol-5-yl)-thio] purine |
| 6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine |
| 6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine |
| 6-1'-Methyl,5'-imidazolyl mercaptopurine |
| 9H-Purine, 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- |
| A 4638 |
| AB0014998 |
| AB00443544 |
| AB00443544_12 |
| AB00443544_13 |
| AB00443544-03 |
| AB00443544-11 |
| AB2000247 |
| AC-4230 |
| AC1L1DAL |
| AC1Q3Z1F |
| ACT02232 |
| AG-670/36150031 |
| AI-981/34845012 |
| AI3-50290 |
| AJ-49795 |
| AK-98682 |
| AKOS005609209 |
| AKOS022184498 |
| AKOS028108935 |
| AN-12213 |
| API0001569 |
| Azamun |
| Azamun (TN) |
| Azamun [Czech] |
| Azamune |
| Azanin |
| azanine |
| Azasan |
| Azasan (TN) |
| Azasan, Imuran and others |
| Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine |
| Azasan;Imuran;Azamun;BW-57-322;NSC-39084 |
| Azathioprin |
| azathioprine |
| Azathioprine (Azasan, Imuran) |
| Azathioprine (JP15/USP/INN) |
| Azathioprine (JP17/USP/INN) |
| Azathioprine [USAN:INN:BAN:JAN] |
| Azathioprine [USAN:USP:INN:BAN:JAN] |
| Azathioprine sodium |
| Azathioprine Sulfate |
| Azathioprine, >=98% |
| Azathioprine, European Pharmacopoeia (EP) Reference Standard |
| Azathioprine, meets USP testing specifications |
| Azathioprine, pharmaceutical secondary standard; traceability to USP, PhEur and BP |
| Azathioprine, United States Pharmacopeia (USP) Reference Standard |
| Azathioprine(Azasan, Imuran) |
| Azathioprinum [INN-Latin] |
| Azathiopurine |
| azathropine |
| azatiopr in |
| Azatioprin |
| Azatioprina |
| Azatioprina [INN-Spanish] |
| Azoran |
| Azothioprin |
| Azothioprine |
| B. W. 57-322 |
| BDBM50373919 |
| BG0097 |
| BPBio1_000054 |
| BRD-K32821942-001-05-6 |
| BRD-K60324116-001-01-5 |
| BSPBio_000048 |
| BSPBio_001876 |
| BW 57-322 |
| BW 57322 |
| BW-57-322 |
| C-17433 |
| C06837 |
| C9H7N7O2S |
| CAS-446-86-6 |
| CBDivE_013132 |
| CC-24218 |
| CCG-16168 |
| CCG-220094 |
| CCG-39877 |
| CCRIS 62 |
| Ccucol |
| CHEBI:2948 |
| CHEMBL1542 |
| ChemDiv1_002659 |
| cMAP_000046 |
| CPD000427366 |
| CS-2241 |
| Cytostatics |
| D00238 |
| D07QCE |
| DB00993 |
| DivK1c_000586 |
| DR000934 |
| DSSTox_CID_119 |
| DSSTox_GSID_20119 |
| DSSTox_RID_75381 |
| DTXSID4020119 |
| EINECS 207-175-4 |
| EU-0100027 |
| FT-0083532 |
| FT-0602904 |
| GP1145 |
| GTPL7120 |
| HE209436 |
| HE343752 |
| HE343753 |
| HMS1568C10 |
| HMS1920E17 |
| HMS2091K19 |
| HMS2095C10 |
| HMS2802J03 |
| HMS3259P03 |
| HMS3260E15 |
| HMS3655M04 |
| HMS501N08 |
| HMS594I19 |
| HSDB 7084 |
| HY-B0256 |
| IDI1_000586 |
| Immuran |
| Imuran (TN) |
| Imurek |
| Imurel |
| Imurel (TN) |
| KBio1_000586 |
| KBio2_000464 |
| KBio2_002427 |
| KBio2_003032 |
| KBio2_004995 |
| KBio2_005600 |
| KBio2_007563 |
| KBio3_001376 |
| KBio3_002906 |
| KBioGR_000646 |
| KBioGR_002427 |
| KBioSS_000464 |
| KBioSS_002433 |
| KS-00000XLZ |
| KS-1146 |
| L996 |
| LMEKQMALGUDUQG-UHFFFAOYSA-N |
| Lopac-A-4638 |
| Lopac0_000027 |
| LP00027 |
| LS-123 |
| MCULE-8637589610 |
| Methylnitroimidazolylmercaptopurine |
| MFCD00069203 |
| MLS001049307 |
| MolPort-000-745-914 |
| MolPort-000-764-262 |
| MRK240IY2L |
| Muran |
| NC00614 |
| NCGC00015060-01 |
| NCGC00015060-02 |
| NCGC00015060-03 |
| NCGC00015060-04 |
| NCGC00015060-05 |
| NCGC00015060-06 |
| NCGC00015060-07 |
| NCGC00015060-08 |
| NCGC00015060-09 |
| NCGC00015060-10 |
| NCGC00015060-11 |
| NCGC00015060-12 |
| NCGC00015060-13 |
| NCGC00015060-14 |
| NCGC00015060-15 |
| NCGC00015060-16 |
| NCGC00015060-18 |
| NCGC00015060-19 |
| NCGC00090836-01 |
| NCGC00090836-02 |
| NCGC00090836-03 |
| NCGC00090836-04 |
| NCGC00090836-05 |
| NCGC00090836-06 |
| NCGC00094593-01 |
| NCGC00094593-02 |
| NCGC00094593-03 |
| NCGC00260712-01 |
| NCI-C03474 |
| NINDS_000586 |
| NSC 39084 |
| NSC-39084 |
| NSC-755900 |
| NSC39084 |
| NSC755900 |
| Oprea1_375441 |
| Oprea1_533384 |
| Oprea1_633462 |
| Pharmakon1600-01500133 |
| Prestwick_41 |
| Prestwick0_000094 |
| Prestwick1_000094 |
| Prestwick2_000094 |
| Prestwick3_000094 |
| PubChem9256 |
| Purine, 6-((1-methyl-4-nitroimidazol-5-yl)thio)- |
| Purine, 6-(1-methyl-4-nitro-5-imidazolylthio)- |
| Purine, 6-[(1-methyl-4-nitroimidazol-5-yl)thio]- |
| s1721 |
| SAM002589938 |
| SBI-0050016.P003 |
| SC-04582 |
| SCHEMBL4278 |
| SDCCGMLS-0065415.P001 |
| SMR000427366 |
| SPBio_000255 |
| SPBio_001987 |
| Spectrum_000064 |
| SPECTRUM1500133 |
| Spectrum2_000068 |
| Spectrum3_000308 |
| Spectrum4_000243 |
| Spectrum5_000848 |
| SR-01000075537 |
| SR-01000075537-1 |
| ST24045004 |
| STK831906 |
| STOCK1S-20293 |
| STOCK1S-27186 |
| Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl) |
| Tox21_110074 |
| Tox21_110074_1 |
| Tox21_400024 |
| Tox21_500027 |
| UNII-MRK240IY2L |
| WLN: T56 BM DN FN HNJ IS- ET5N CNJ A1 DNW |
| Z57063156 |
| ZINC4258316 |
US Patents and Regulatory Information for IMURAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Casper Pharma Llc | IMURAN | azathioprine sodium | INJECTABLE;INJECTION | 017391-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Sebela Ireland Ltd | IMURAN | azathioprine | TABLET;ORAL | 016324-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Sebela Ireland Ltd | IMURAN | azathioprine | TABLET;ORAL | 016324-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
